Your browser doesn't support javascript.
loading
Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors.
Qiao, Guoliang; Wang, Xiaoli; Zhou, Xinna; Morse, Michael A; Wu, Jiangping; Wang, Shuo; Song, Yuguang; Jiang, Ni; Zhao, Yanjie; Zhou, Lei; Zhao, Jing; Di, Yan; Zhu, Lihong; Hobeika, Amy; Ren, Jun; Lyerly, Herbert Kim.
Affiliation
  • Qiao G; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Wang X; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhou X; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Morse MA; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Wu J; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Wang S; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Song Y; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Jiang N; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhao Y; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhou L; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhao J; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Di Y; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhu L; Department of Gynecological Oncology, Beijing Gynecology Hospital, Capital Medical University, Beijing, China.
  • Hobeika A; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Ren J; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Lyerly HK; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Int J Hyperthermia ; 36(sup1): 74-82, 2019 11.
Article in En | MEDLINE | ID: mdl-31795830
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Hyperthermia, Induced / Neoplasms Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Int J Hyperthermia Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2019 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Hyperthermia, Induced / Neoplasms Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Int J Hyperthermia Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2019 Type: Article Affiliation country: China